Tiragolumab Combo Fails to Improve Survival in Untreated Extensive-Stage SCLC
1. Median PFS and OS between the tiragolumab and control arms were similar 2. Treatment-related...
Read MoreDec 15, 2023
1. Median PFS and OS between the tiragolumab and control arms were similar 2. Treatment-related...
Read MoreDec 14, 2023
1. Methotrexate 20 mg once weekly resulted in significant pain reduction among patients with hand...
Read MoreDec 13, 2023
1. Patients in the thrombectomy group reported significantly greater improvement, with lower...
Read MoreDec 9, 2023
Click here to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved. No...
Read MoreDec 9, 2023
Click here to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved. No...
Read MoreDec 9, 2023
Click here to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved. No...
Read MoreDec 7, 2023
Click here to read this study in JAMA Otolaryngology-Head and Neck Surgery. ©2023 2 Minute...
Read MoreDec 6, 2023
1. Patients who underwent the Ross procedure had a comparable survival rate to a matched general...
Read MoreDec 2, 2023
Click here to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved. No...
Read MoreDec 2, 2023
Click here to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved. No...
Read MoreDec 1, 2023
Click here to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved. No...
Read MoreNov 30, 2023
Click here to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved. No...
Read MoreNov 29, 2023
1. The augmentation of usual intraoperative care with support from the Anesthesiology Control...
Read MoreNov 25, 2023
Click here to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved. No...
Read MoreNov 24, 2023
Click here to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved. No...
Read MoreNov 24, 2023
Click here to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved. No...
Read MoreNov 23, 2023
Click here to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved. No...
Read MoreNov 21, 2023
Click here to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved. No...
Read MoreNov 18, 2023
1. The progression-free survival in berzosertib with topotecan vs topotecan alone was not...
Read MoreNov 18, 2023
Click here to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved. No...
Read More